Latebreakers: Antifungal approved for new indication
Mycamine from Astellas Pharma was given a supplemental indication approval
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
